What is it about?
Dulaglutide is GLP-1 receptor agonist. This compound is indicated for adults with type 2 diabetes mellitus as an adjunct to diet and exercise to improve glycemic control. This paper concludes the risk and benefit profile of dulaglutide.
Featured Image
Why is it important?
Our findings give the unlisted serious risks associated with dulaglutide which may be taken into account for further safety studies.
Perspectives
Writing this article was a great pleasure as it has my mentor as co-author and learned many things while writing it.
Aakriti Garg
Indo Soviet Friendship College of Pharmacy
Read the Original
This page is a summary of: Risk and Benefit Profile of Dulaglutide in Established Therapeutic Indication, Current Drug Safety, September 2018, Bentham Science Publishers,
DOI: 10.2174/1574886313666180601082412.
You can read the full text:
Contributors
The following have contributed to this page
